0
Correspondence |

Posterior Reversible Encephalopathy Syndrome: Imperative to Define

Hong-Liang Zhang, MD; Xi-Jing Mao, MD, PhD; Xiang-Yu Zheng, MD; Jiang Wu, MD, PhD
[+] Author Affiliations

Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
Arch Neurol. 2010;67(12):1535-1535. doi:10.1001/archneurol.2010.313
Text Size: A A A
Published online

Posterior reversible encephalopathy syndrome (PRES) (also termed reversible posterior leukoencephalopathy syndrome) represents an entity with an underlying pathophysiological mechanism suggested to be vasogenic edema.1 Burrus and colleagues2 reported up to 48% PRES in patients with thrombotic thrombocytopenic purpura (TTP) and acute brain abnormalities. We agree that diffusion-weighted imaging and apparent diffusion coefficient mapping are indispensible to differentiation of vasogenic edema from cytotoxic edema in PRES. However, we have some concern regarding their definition of PRES.

Though PRES appeared common, as defined by the authors and others,3 we ascribe this prevalence to the misunderstanding of PRES. Reversible brain vasogenic edema may concomitantly occur with multiple disorders, including mitochondrial encephalopathy,4 cerebral ischemia,5 and hepatic encephalopathy.6 The reversibility of vasogenic edema, preferably involving posterior white matter, can unambiguously differentiate PRES, primarily arising from failure of cerebrovascular autoregulation at high blood pressure and ensuing disruption of the blood-brain barrier7 by said disorders. In this regard, it seems problematic to equate reversible brain vasogenic edema with PRES, as it might lead to overestimation of incidence of PRES.

In summary, PRES represents a neurological disorder characterized by reversible brain vasogenic edema primarily arising from failure of cerebrovascular autoregulation and disruption of the blood-brain barrier, mainly implicating posterior white matter. Definition of PRES by consensus remains imperative.

AUTHOR INFORMATION

Correspondence: Dr Zhang, MD, Karolinska Institute, Department of Neurobiology, Care and Sciences Society, Novum, Plan 5, SE 141 86, Stockholm, Sweden (hongliang.zhang@ki.se).

Financial Disclosure: None reported.

REFERENCES

Lee  VH, Wijdicks  EF, Manno  EM, Rabinstein  AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008;65 (2) 205- 210
PubMed
Burrus  TM, Mandrekar  J, Wijdicks  EFM, Rabinstein  AA. Renal failure and posterior reversible encephalopathy syndrome in patients with thrombotic thrombocytopenic purpura. Arch Neurol 2010;67 (7) 831- 834
PubMed
Fugate  JE, Claassen  DO, Cloft  HJ, Kallmes  DF, Kozak  OS, Rabinstein  AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010;85 (5) 427- 432
PubMed
Ito  H, Mori  K, Kagami  S. Neuroimaging of stroke-like episodes in MELAS [published online July 5, 2010]. Brain Dev
PubMed
Ikegame  Y, Yamashita  K, Hayashi  S, Yoshimura  S, Nakashima  S, Iwama  T. Neutrophil elastase inhibitor prevents ischemic brain damage via reduction of vasogenic edema. Hypertens Res 2010;33 (7) 703- 707
PubMed
Poveda  MJ, Bernabeu  A, Concepción  L.  et al.  Brain edema dynamics in patients with overt hepatic encephalopathy A magnetic resonance imaging study. Neuroimage 2010;52 (2) 481- 487
PubMed
Bartynski  WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29 (6) 1043- 1049
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Lee  VH, Wijdicks  EF, Manno  EM, Rabinstein  AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008;65 (2) 205- 210
PubMed
Burrus  TM, Mandrekar  J, Wijdicks  EFM, Rabinstein  AA. Renal failure and posterior reversible encephalopathy syndrome in patients with thrombotic thrombocytopenic purpura. Arch Neurol 2010;67 (7) 831- 834
PubMed
Fugate  JE, Claassen  DO, Cloft  HJ, Kallmes  DF, Kozak  OS, Rabinstein  AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010;85 (5) 427- 432
PubMed
Ito  H, Mori  K, Kagami  S. Neuroimaging of stroke-like episodes in MELAS [published online July 5, 2010]. Brain Dev
PubMed
Ikegame  Y, Yamashita  K, Hayashi  S, Yoshimura  S, Nakashima  S, Iwama  T. Neutrophil elastase inhibitor prevents ischemic brain damage via reduction of vasogenic edema. Hypertens Res 2010;33 (7) 703- 707
PubMed
Poveda  MJ, Bernabeu  A, Concepción  L.  et al.  Brain edema dynamics in patients with overt hepatic encephalopathy A magnetic resonance imaging study. Neuroimage 2010;52 (2) 481- 487
PubMed
Bartynski  WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29 (6) 1043- 1049
PubMed

Correspondence

December 13, 2010
Hong-Liang Zhang, MD; Xi-Jing Mao, MD, PhD; Xiang-Yu Zheng, MD; Jiang Wu, MD, PhD
Arch Neurol. 2010;67(12):1535-1535.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles